180-Day Exclusivity in Generic Drug Market Entry: How Patent Law Shapes Drug Prices
180-day exclusivity under the Hatch-Waxman Act gives the first generic drug challenger a temporary monopoly to incentivize patent challenges. But delays in market entry can block competition for years, keeping prices high for patients.
